Risedon Tablet 35 mg (Risedronic Acid Sodium)

Adult dose

Adults: Administer risedronate sodium 35 mg orally once weekly. No dosage adjustment is necessary in elderly patients (over 60 years) because the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or more. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30 mL/min. Food interferes with the absorption of this medicine. For adequate absorption, take it at least 30 minutes before breakfast or at least 2 hours before or after consuming food or beverages at any time during the day. To allow this medicine to reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking this medicine with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. If a patient forgets to take this medicine on the scheduled day, take it the next morning when remembered. Resume taking it on the originally scheduled day for the next dose. Do not take 2 tablets on the same day.

Child dose

Children under 18 years: Safety and efficacy have not been established.

This medication may irritate the upper gastrointestinal mucosa, so patients with issues in the esophagus or stomach should use it with caution. If symptoms such as esophagitis, esophageal ulcer, or dysphagia occur, immediately stop taking the medication and consult a doctor. When taking this medication, it should be consumed while sitting or standing with a sufficient amount of water, and it is important to remain upright for at least 30 minutes after taking the medication. This medication should not be used in patients with esophageal stricture or delayed esophageal evacuation, hypocalcemia, pregnant women, or patients with severe renal impairment. Patients with lactose intolerance should be cautious as issues may arise due to the ingredients in this medication. Careful administration is required for patients with upper gastrointestinal disorders such as Barrett's esophagus or gastritis. During the intake of this medication, gastrointestinal symptoms, musculoskeletal pain, headache, allergic reactions, etc. may occur, and if any abnormal symptoms persist, the patient should inform a doctor. With prolonged use, serious side effects such as osteonecrosis of the jaw or atypical fractures may rarely occur, so regular check-ups and management are necessary. Do not take this medication simultaneously with calcium, magnesium, iron-containing medications or foods, but rather take them several hours before or after meals. Pregnant or breastfeeding women should not use this medication; if breastfeeding, either discontinue use or stop breastfeeding. Safety in children under 18 has not been established, and use should be avoided. Overdose may cause hypocalcemia, necessitating an immediate visit to a medical institution for appropriate treatment. Store this medication out of reach of children and avoid transferring it to other containers.

• esophagitis
• esophageal ulcer
• esophageal erosion
• esophageal obstruction
• esophageal perforation
• bleeding
• infection
• back pain
• accidental injury
• pain

This medication should be stored in an airtight container, kept in a temperature range of 1 to 30 degrees Celsius. Proper storage helps maintain the medication’s effectiveness and prevents degradation.

Appearance

Light orange oval film-coated tablet

Package unit

4 tablets/ptp